Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
AbstractTransplantation of human pluripotent stem cell (hPSCs)-derived cardiomyocytes for the treatment of heart failure is a promising therapy. In order to implement this therapy requiring numerous cardiomyocytes, substantial production of hPSCs followed by cardiac differentiation seems practical. Conventional methods of culturing hPSCs involve using a 2D culture monolayer that hinders the expansion of hPSCs, thereby limiting their productivity. Advanced culture of hPSCs in 3D aggregates in the suspension overcomes the limitations of 2D culture and attracts immense attention. Although the hPSC production needs to be suitable for subsequent cardiac differentiation, many studies have independently focused on either expansion of hPSCs or cardiac differentiation protocols. In this review, we summarize the recent approaches to expand hPSCs in combination with cardiomyocyte differentiation. A comparison of various suspension culture methods and future prospects for dynamic culture of hPSCs are discussed in this study. Understanding hPSC characteristics in different models of dynamic culture helps to produce numerous cells that are useful for further clinical applications. View Full-Text
Share & Cite This Article
Le, M.N.T.; Hasegawa, K. Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes. Bioengineering 2019, 6, 48.
Le MNT, Hasegawa K. Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes. Bioengineering. 2019; 6(2):48.Chicago/Turabian Style
Le, Minh N.T.; Hasegawa, Kouichi. 2019. "Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes." Bioengineering 6, no. 2: 48.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.